- Struggling Novavax details wave of red ink and charts survival course after triggering ‘business continuity’ alertTerminal News
- Novavax shares plunge as company raises doubts about ability to stay in businessCNBC
- Novavax down 23% after Q4 2022 results miss upper and lower lines (NASDAQ: NVAX)Looking for Alpha
- Novavax declares “substantial doubt” around the continuation of its activitiesBarrons
- Novavax Reports Financial Results and Operational Highlights for the Fourth Quarter and Full Year 2022PR Newswire
- See full coverage on Google News